United States Pharmaceuticals

AMAG Pharmaceuticals Inc (AMAG)

Track

Track

Ticker: AMAG Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
21.99
Quantity 81,548 +26.6%
Value US$3,949,517
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
277.44
Quantity 70,759 -45.9%
Value US$2,684,418
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
8.29
Quantity 24,000 +8.3%
Value US$198,960
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.41
Quantity 8,000 +2.9%
Value US$75,280
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.43
Quantity 8,000 +0.2%
Value US$75,440
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.72
Quantity 40,000 +16.7%
Value US$388,800
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.58
Quantity 34,000 +0.8%
Value US$325,720
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
11.64
Quantity 18,000 +0.4%
Value US$209,520
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
12.33
Quantity 12,466 +0.3%
Value US$153,706
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Sale
Price
12.43
Quantity 12,466 -0.3%
Value US$154,952
Camber Capital Management LP
Transaction date
Purchase
Price
9.18
Quantity 3,400 +0.1%
Value US$31,206
Camber Capital Management LP
Transaction date
Purchase
Price
8.94
Quantity 26,600 +0.6%
Value US$237,791
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
7.43
Quantity 40,000 +20.0%
Value US$297,200
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
0.00
Quantity 0
Value US$0
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
7.32
Quantity 260,000 +6.8%
Value US$1,903,200
Camber Capital Management LP
Transaction date
Purchase
Price
7.58
Quantity 4,000 +0.1%
Value US$30,300
Camber Capital Management LP
Transaction date
Purchase
Price
7.74
Quantity 50,000 +1.2%
Value US$387,000
Camber Capital Management LP
Transaction date
Purchase
Price
7.79
Quantity 301,000 +7.5%
Value US$2,343,496
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.47
Quantity 20,000 +11.1%
Value US$189,400
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.52
Quantity 44,000 +1.2%
Value US$418,880
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
9.13
Quantity 120,000 +3.3%
Value US$1,095,600
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
8.86
Quantity 30,000 +20.0%
Value US$265,800
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
8.85
Quantity 25,000 +20.0%
Value US$221,250
2.5
ARMISTICE CAPITAL, LLC Large shareholder
Transaction date
Purchase
Price
8.59
Quantity 259,016 +7.7%
Value US$2,224,947
Krop Julie Chief Medical Officer
Transaction date
Purchase
Price
9.91
Quantity 10,000 +14.0%
Value US$99,100
Bolgiano Elizabeth Scott Chief Human Resources Officer
Transaction date
Purchase
Price
10.93
Quantity 5,000 +7.2%
Value US$54,650
3.7
HEIDEN WILLIAM K President & CEO Executive Director
Transaction date
Purchase
Price
10.70
Quantity 10,000 +2.1%
Value US$107,000
3.0
Vittiglio Joseph EVP, General Counsel
Transaction date
Planned sale
Price
14.01
Quantity 1,425 -1.8%
Value US$19,964
HEIDEN WILLIAM K President & CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 5,000 -1.5%
Value US$125,000
HEIDEN WILLIAM K President & CEO Executive Director
Transaction date
Planned sale
Price
25.00
Quantity 20,000 -5.7%
Value US$500,000
Vittiglio Joseph EVP, General Counsel
Transaction date
Planned sale
Price
20.80
Quantity 770 -1.4%
Value US$16,016
Vittiglio Joseph SVP, General Counsel
Transaction date
Planned sale
Price
16.75
Quantity 1,250 -3.6%
Value US$20,938
Krop Julie SVP Clinical & Regulatory, CMO Officer
Transaction date
Planned sale
Price
20.00
Quantity 4,938 -14.8%
Value US$98,760
Krop Julie SVP Clinical & Regulatory, CMO Officer
Transaction date
Planned sale
Price
24.45
Quantity 1,891 -4.9%
Value US$46,235
Krop Julie SVP Clinical & Regulatory, CMO Officer
Transaction date
Planned sale
Price
24.80
Quantity 4,938 -17.3%
Value US$122,462
Fallon John A. Non-Executive Director
Transaction date
Purchase
Price
31.20
Quantity 3,230 +113.1%
Value US$100,776
THOMAS FRANK E President & COO Officer
Transaction date
Planned sale
Price
66.85
Quantity 15,000 -12.1%
Value US$1,002,750
HEIDEN WILLIAM K CEO Executive Director
Transaction date
Planned sale
Price
75.00
Quantity 20,000 -8.8%
Value US$1,500,000
Holmes Scott A SVP, Finance and Treasurer Officer
Transaction date
Planned sale
Price
66.63
Quantity 6,234 -10.7%
Value US$415,371
HEIDEN WILLIAM K CEO Executive Director
Transaction date
Planned sale
Price
71.52
Quantity 12,128 -5.5%
Value US$867,395
HEIDEN WILLIAM K CEO Executive Director
Transaction date
Planned sale
Price
70.69
Quantity 4,680 -2.1%
Value US$330,829
HEIDEN WILLIAM K CEO Executive Director
Transaction date
Planned sale
Price
69.77
Quantity 36,550 -13.9%
Value US$2,550,094
HEIDEN WILLIAM K CEO Executive Director
Transaction date
Planned sale
Price
68.90
Quantity 6,642 -2.5%
Value US$457,634
THOMAS FRANK E President & COO Officer
Transaction date
Sale
Price
69.76
Quantity 7,996 -6.8%
Value US$557,801
THOMAS FRANK E President & COO Officer
Transaction date
Sale
Price
69.27
Quantity 12,004 -9.3%
Value US$831,517
Wilson Kenneth H SVP, Sales and Marketing Officer
Transaction date
Sale
Price
68.77
Quantity 5,388 -17.7%
Value US$370,533
Holmes Scott A SVP, Finance and Treasurer Officer
Transaction date
Sale
Price
68.88
Quantity 22,516 -42.2%
Value US$1,550,902
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Sale
Price
43.48
Quantity 17,493 -0.7%
Value US$760,596
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Sale
Price
46.00
Quantity 25,169 -1.0%
Value US$1,157,774
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Sale
Price
46.25
Quantity 10,000 -0.4%
Value US$462,500
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Sale
Price
45.90
Quantity 55,000 -2.1%
Value US$2,524,500
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Sale
Price
46.11
Quantity 52,338 -1.9%
Value US$2,413,305
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Sale
Price
46.60
Quantity 1,090,000 -28.7%
Value US$50,794,000
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
21.58
Quantity 400 -1.6%
Value US$8,632
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
22.41
Quantity 200 -0.8%
Value US$4,482
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
21.40
Quantity 100 -0.4%
Value US$2,140
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
20.61
Quantity 1,700 -6.3%
Value US$35,037
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
24.10
Quantity 2,500 -8.0%
Value US$60,250
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
16.37
Quantity 400 -100.0%
Value US$6,548
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
16.39
Quantity 433 -52.0%
Value US$7,097
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
15.80
Quantity 3,000 -100.0%
Value US$47,407
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
15.87
Quantity 3,000 -50.0%
Value US$47,600
White Christopher G Chief Business Officer Officer
Transaction date
Planned sale
Price
16.03
Quantity 4,000 -40.0%
Value US$64,102
THOMAS FRANK E EVP, COO Officer
Transaction date
Planned sale
Price
15.60
Quantity 10,000 -31.2%
Value US$155,969
Holmes Scott A Chief Accounting Officer Officer
Transaction date
Planned sale
Price
14.79
Quantity 2,500 -100.0%
Value US$36,975
Holmes Scott A Chief Accounting Officer Officer
Transaction date
Planned sale
Price
15.54
Quantity 750 -100.0%
Value US$11,655
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-10-05 2020-10-01 S Sale
3.0
Camber Capital Management LP
Large shareholder
66,518 +5.4%
262.75
US$401,924 		66,518 +5.4% 262.75 US$401,924
2020-03-18 2020-03-16 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
81,548 +26.6%
21.99
US$3,949,517 		81,548 +26.6% 21.99 US$3,949,517
2020-02-27 2020-02-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
70,759 -45.9%
277.44
US$2,684,418 		70,759 -45.9% 277.44 US$2,684,418
2020-02-27 2020-02-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
24,000 +8.3%
8.29
US$198,960 		24,000 +8.3% 8.29 US$198,960
2020-01-28 2020-01-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
8,000 +2.9%
9.41
US$75,280 		8,000 +2.9% 9.41 US$75,280
2020-01-28 2020-01-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-28 2020-01-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
8,000 +0.2%
9.43
US$75,440 		8,000 +0.2% 9.43 US$75,440
2020-01-28 2020-01-24 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
40,000 +16.7%
9.72
US$388,800 		40,000 +16.7% 9.72 US$388,800
2020-01-28 2020-01-24 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-28 2020-01-24 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
34,000 +0.8%
9.58
US$325,720 		34,000 +0.8% 9.58 US$325,720
2020-01-13 2020-01-10 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-13 2020-01-10 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
18,000 +0.4%
11.64
US$209,520 		18,000 +0.4% 11.64 US$209,520
2020-01-13 2020-01-09 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-13 2020-01-09 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
12,466 +0.3%
12.33
US$153,706 		12,466 +0.3% 12.33 US$153,706
2020-01-13 2020-01-09 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-13 2020-01-09 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
12,466 -0.3%
12.43
US$154,952 		12,466 -0.3% 12.43 US$154,952
2019-08-09 2019-08-09 B Purchase Camber Capital Management LP
3,400 +0.1%
9.18
US$31,206 		3,400 +0.1% 9.18 US$31,206
2019-08-09 2019-08-09 B Purchase Camber Capital Management LP
26,600 +0.6%
8.94
US$237,791 		26,600 +0.6% 8.94 US$237,791
2019-08-09 2019-08-07 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
40,000 +20.0%
7.43
US$297,200 		40,000 +20.0% 7.43 US$297,200
2019-08-09 2019-08-07 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-08-09 2019-08-07 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
260,000 +6.8%
7.32
US$1,903,200 		260,000 +6.8% 7.32 US$1,903,200
2019-08-09 2019-08-07 B Purchase Camber Capital Management LP
4,000 +0.1%
7.58
US$30,300 		4,000 +0.1% 7.58 US$30,300
2019-08-09 2019-08-07 B Purchase Camber Capital Management LP
50,000 +1.2%
7.74
US$387,000 		50,000 +1.2% 7.74 US$387,000
2019-08-09 2019-08-07 B Purchase Camber Capital Management LP
301,000 +7.5%
7.79
US$2,343,496 		301,000 +7.5% 7.79 US$2,343,496
2019-06-27 2019-06-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
20,000 +11.1%
9.47
US$189,400 		20,000 +11.1% 9.47 US$189,400
2019-06-27 2019-06-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-27 2019-06-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
44,000 +1.2%
9.52
US$418,880 		44,000 +1.2% 9.52 US$418,880
2019-06-27 2019-06-26 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-27 2019-06-26 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
120,000 +3.3%
9.13
US$1,095,600 		120,000 +3.3% 9.13 US$1,095,600
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
30,000 +20.0%
8.86
US$265,800 		30,000 +20.0% 8.86 US$265,800
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
25,000 +20.0%
8.85
US$221,250 		25,000 +20.0% 8.85 US$221,250
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
259,016 +7.7%
8.59
US$2,224,947 		259,016 +7.7% 8.59 US$2,224,947
2019-05-29 2019-05-28 B Purchase
Krop Julie

Chief Medical Officer
10,000 +14.0%
9.91
US$99,100 		10,000 +14.0% 9.91 US$99,100
2019-05-09 2019-05-09 B Purchase
Bolgiano Elizabeth Scott

Chief Human Resources Officer
5,000 +7.2%
10.93
US$54,650 		5,000 +7.2% 10.93 US$54,650
2019-05-09 2019-05-09 B Purchase
3.7
HEIDEN WILLIAM K

President & CEO

Executive Director
10,000 +2.1%
10.70
US$107,000 		10,000 +2.1% 10.70 US$107,000
2019-03-11 2019-03-07 PlS Planned sale
3.0
Vittiglio Joseph

EVP, General Counsel
1,425 -1.8%
14.01
US$19,964 		1,425 -1.8% 14.01 US$19,964
2018-08-08 2018-08-07 PlS Planned sale HEIDEN WILLIAM K

President & CEO

Executive Director
5,000 -1.5%
25.00
US$125,000 		5,000 -1.5% 25.00 US$125,000
2018-06-05 2018-06-04 PlS Planned sale HEIDEN WILLIAM K

President & CEO

Executive Director
20,000 -5.7%
25.00
US$500,000 		20,000 -5.7% 25.00 US$500,000
2018-03-06 2018-03-06 PlS Planned sale Vittiglio Joseph

EVP, General Counsel
770 -1.4%
20.80
US$16,016 		770 -1.4% 20.80 US$16,016
2017-08-30 2017-08-29 PlS Planned sale Vittiglio Joseph

SVP, General Counsel
1,250 -3.6%
16.75
US$20,938 		1,250 -3.6% 16.75 US$20,938
2017-07-14 2017-07-13 PlS Planned sale Krop Julie

SVP Clinical & Regulatory, CMO

Officer
4,938 -14.8%
20.00
US$98,760 		4,938 -14.8% 20.00 US$98,760
2017-05-02 2017-05-01 PlS Planned sale Krop Julie

SVP Clinical & Regulatory, CMO

Officer
1,891 -4.9%
24.45
US$46,235 		1,891 -4.9% 24.45 US$46,235
2016-10-20 2016-10-20 PlS Planned sale Krop Julie

SVP Clinical & Regulatory, CMO

Officer
4,938 -17.3%
24.80
US$122,462 		4,938 -17.3% 24.80 US$122,462
2015-11-10 2015-11-10 B Purchase Fallon John A. Non-Executive Director
3,230 +113.1%
31.20
US$100,776 		3,230 +113.1% 31.20 US$100,776
2015-08-07 2015-08-05 PlS Planned sale THOMAS FRANK E

President & COO

Officer
15,000 -12.1%
66.85
US$1,002,750 		15,000 -12.1% 66.85 US$1,002,750
2015-07-17 2015-07-15 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
20,000 -8.8%
75.00
US$1,500,000 		20,000 -8.8% 75.00 US$1,500,000
2015-06-17 2015-06-15 PlS Planned sale Holmes Scott A

SVP, Finance and Treasurer

Officer
6,234 -10.7%
66.63
US$415,371 		6,234 -10.7% 66.63 US$415,371
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
12,128 -5.5%
71.52
US$867,395 		12,128 -5.5% 71.52 US$867,395
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
4,680 -2.1%
70.69
US$330,829 		4,680 -2.1% 70.69 US$330,829
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
36,550 -13.9%
69.77
US$2,550,094 		36,550 -13.9% 69.77 US$2,550,094
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
6,642 -2.5%
68.90
US$457,634 		6,642 -2.5% 68.90 US$457,634
2015-06-08 2015-06-04 S Sale THOMAS FRANK E

President & COO

Officer
7,996 -6.8%
69.76
US$557,801 		7,996 -6.8% 69.76 US$557,801
2015-06-08 2015-06-04 S Sale THOMAS FRANK E

President & COO

Officer
12,004 -9.3%
69.27
US$831,517 		12,004 -9.3% 69.27 US$831,517
2015-06-05 2015-06-03 S Sale Wilson Kenneth H

SVP, Sales and Marketing

Officer
5,388 -17.7%
68.77
US$370,533 		5,388 -17.7% 68.77 US$370,533
2015-06-05 2015-06-03 S Sale Holmes Scott A

SVP, Finance and Treasurer

Officer
22,516 -42.2%
68.88
US$1,550,902 		22,516 -42.2% 68.88 US$1,550,902
2015-01-09 2015-01-09 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
17,493 -0.7%
43.48
US$760,596 		17,493 -0.7% 43.48 US$760,596
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,169 -1.0%
46.00
US$1,157,774 		25,169 -1.0% 46.00 US$1,157,774
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
10,000 -0.4%
46.25
US$462,500 		10,000 -0.4% 46.25 US$462,500
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
55,000 -2.1%
45.90
US$2,524,500 		55,000 -2.1% 45.90 US$2,524,500
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
52,338 -1.9%
46.11
US$2,413,305 		52,338 -1.9% 46.11 US$2,413,305
2015-01-09 2015-01-07 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
1,090,000 -28.7%
46.60
US$50,794,000 		1,090,000 -28.7% 46.60 US$50,794,000
2014-02-26 2014-02-26 PlS Planned sale White Christopher G

Chief Business Officer

Officer
400 -1.6%
21.58
US$8,632 		400 -1.6% 21.58 US$8,632
2014-01-09 2014-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
200 -0.8%
22.41
US$4,482 		200 -0.8% 22.41 US$4,482
2014-01-09 2014-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
100 -0.4%
21.40
US$2,140 		100 -0.4% 21.40 US$2,140
2014-01-09 2014-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
1,700 -6.3%
20.61
US$35,037 		1,700 -6.3% 20.61 US$35,037
2014-01-07 2014-01-07 PlS Planned sale White Christopher G

Chief Business Officer

Officer
2,500 -8.0%
24.10
US$60,250 		2,500 -8.0% 24.10 US$60,250
2013-02-26 2013-02-26 PlS Planned sale White Christopher G

Chief Business Officer

Officer
400 -100.0%
16.37
US$6,548 		400 -100.0% 16.37 US$6,548
2013-02-26 2013-02-25 PlS Planned sale White Christopher G

Chief Business Officer

Officer
433 -52.0%
16.39
US$7,097 		433 -52.0% 16.39 US$7,097
2013-01-09 2013-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
3,000 -100.0%
15.80
US$47,407 		3,000 -100.0% 15.80 US$47,407
2013-01-09 2013-01-08 PlS Planned sale White Christopher G

Chief Business Officer

Officer
3,000 -50.0%
15.87
US$47,600 		3,000 -50.0% 15.87 US$47,600
2013-01-07 2013-01-04 PlS Planned sale White Christopher G

Chief Business Officer

Officer
4,000 -40.0%
16.03
US$64,102 		4,000 -40.0% 16.03 US$64,102
2013-01-04 2013-01-03 PlS Planned sale THOMAS FRANK E

EVP, COO

Officer
10,000 -31.2%
15.60
US$155,969 		10,000 -31.2% 15.60 US$155,969
2012-12-06 2012-12-05 PlS Planned sale Holmes Scott A

Chief Accounting Officer

Officer
2,500 -100.0%
14.79
US$36,975 		2,500 -100.0% 14.79 US$36,975
2012-09-13 2012-09-12 PlS Planned sale Holmes Scott A

Chief Accounting Officer

Officer
750 -100.0%
15.54
US$11,655 		750 -100.0% 15.54 US$11,655
Explore more

More insider trading research around AMAG Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America